129 related articles for article (PubMed ID: 33812493)
1. Low-dose aspirin and mesalazine for patients with familial adenomatous polyposis.
Lynch PM
Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):418-419. PubMed ID: 33812493
[No Abstract] [Full Text] [Related]
2. Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial.
Ishikawa H; Mutoh M; Sato Y; Doyama H; Tajika M; Tanaka S; Horimatsu T; Takeuchi Y; Kashida H; Tashiro J; Ezoe Y; Nakajima T; Ikematsu H; Hori S; Suzuki S; Otani T; Takayama T; Ohda Y; Mure K; Wakabayashi K; Sakai T
Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):474-481. PubMed ID: 33812492
[TBL] [Abstract][Full Text] [Related]
3. Utility of Mesalazine in Familial Adenomatous Polyposis: Clinical Report of Reduction of Polyp Size in Patients with Ulcerative Colitis, and Safety Examination in Familial Adenomatous Polyposis Patients.
Ishikawa H; Mutoh M; Abe T; Nakajima T; Takeuchi Y; Ezoe Y; Wakabayashi K; Doyama H; Sakai T
Pharmacology; 2019; 104(1-2):51-56. PubMed ID: 31067545
[TBL] [Abstract][Full Text] [Related]
4. Aspirin and familial adenomatous polyposis: coming full circle.
Chan AT
Cancer Prev Res (Phila); 2011 May; 4(5):623-7. PubMed ID: 21543340
[TBL] [Abstract][Full Text] [Related]
5. Sulindac therapy for familial adenomatous polyposis after colectomy and ileorectal anastomosis.
Mäkelä JT; Laitinen S
Ann Chir Gynaecol; 1994; 83(3):265-7. PubMed ID: 7857074
[TBL] [Abstract][Full Text] [Related]
6. Can we safely delay or avoid prophylactic colectomy in familial adenomatous polyposis?
Phillips RK; Spigelman AD
Br J Surg; 1996 Jun; 83(6):769-70. PubMed ID: 8696735
[No Abstract] [Full Text] [Related]
7. [Colorectal cancer prevention of familial adenomatous polyposis].
Ishikawa H
Nihon Shokakibyo Gakkai Zasshi; 2016 Jul; 113(7):1191-5. PubMed ID: 27383102
[No Abstract] [Full Text] [Related]
8. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
[TBL] [Abstract][Full Text] [Related]
9. [Role of suindac in the treatment of familial adenomatous polyposis coli].
Landauer S; Halimi C; Caulin C; Bergmann JF
Therapie; 1999; 54(6):675-82. PubMed ID: 10709439
[TBL] [Abstract][Full Text] [Related]
10. The protocol for a European double-blind trial of aspirin and resistant starch in familial adenomatous polyposis: the CAPP study. Concerted Action Polyposis Prevention.
Burn J; Chapman PD; Mathers J; Bertario L; Bishop DT; Bülow S; Cummings J; Phillips R; Vasen H
Eur J Cancer; 1995; 31A(7-8):1385-6. PubMed ID: 7577057
[No Abstract] [Full Text] [Related]
11. The role of sulindac in familial adenomatous polyposis patients with ileal pouch polyposis.
Ho JW; Yuen ST; Chung LP; So HC; Kwan KY
Aust N Z J Surg; 1999 Oct; 69(10):756-8. PubMed ID: 10527361
[No Abstract] [Full Text] [Related]
12. Chemoprevention of familial adenomatous polyposis.
Lynch PM
Fam Cancer; 2016 Jul; 15(3):467-75. PubMed ID: 27083160
[TBL] [Abstract][Full Text] [Related]
13. Familial adenomatous polyposis as a precancerosis of colon cancer.
Vavra P; Dostalik J; Martinek L; Zonca P; Plevova P; Kohoutova M; Stekrova J
Bratisl Lek Listy; 2002; 103(11):418-21. PubMed ID: 12585356
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and functional outcome for individuals who underwent very early colectomy for familial adenomatous polyposis.
Durno CA; Wong J; Berk T; Alingary N; Cohen Z; Esplen MJ
Dis Colon Rectum; 2012 Apr; 55(4):436-43. PubMed ID: 22426268
[TBL] [Abstract][Full Text] [Related]
15. Familial adenomatous polyposis in children younger than age ten years: a multidisciplinary clinic experience.
Attard TM; Tajouri T; Peterson KD; Tinley S; Thorson AG; Lynch HT
Dis Colon Rectum; 2008 Feb; 51(2):207-12. PubMed ID: 18157572
[TBL] [Abstract][Full Text] [Related]
16. A Decision Analysis for Rectal-Sparing Familial Adenomatous Polyposis: Total Colectomy With Ileorectal Anastomosis Versus Proctocolectomy With IPAA.
Melnitchouk N; Saadat LV; Bleday R; Goldberg JE
Dis Colon Rectum; 2019 Jan; 62(1):27-32. PubMed ID: 30394986
[TBL] [Abstract][Full Text] [Related]
17. Life After Surgery: Surgeon Assessments of Quality of Life Among Patients With Familial Adenomatous Polyposis.
Dossa F; Morris AM; Wilson AR; Baxter NN
Dis Colon Rectum; 2018 Oct; 61(10):1217-1222. PubMed ID: 30192330
[TBL] [Abstract][Full Text] [Related]
18. [Rectal carcinoma in a patient with familial adenomatous polyposis coli after colectomy with ileorectal anastomosis and consecutive chemoprevention with sulindac suppositories].
Utech M; Brüwer M; Buerger H; Tübergen D; Senninger N
Chirurg; 2002 Aug; 73(8):855-8. PubMed ID: 12425165
[TBL] [Abstract][Full Text] [Related]
19. Risk of rectal cancer in patients after colectomy and ileorectal anastomosis for familial adenomatous polyposis: a function of available surgical options.
Church J; Burke C; McGannon E; Pastean O; Clark B
Dis Colon Rectum; 2003 Sep; 46(9):1175-81. PubMed ID: 12972960
[TBL] [Abstract][Full Text] [Related]
20. Reassessing colectomy in young patients with familial adenomatous polyposis.
Cruz-Correa M; Gonzalez-Pons MDM
Gastrointest Endosc; 2018 Oct; 88(4):734-736. PubMed ID: 30217246
[No Abstract] [Full Text] [Related]
[Next] [New Search]
